命得生注射劑

Pays: Taïwan

Langue: chinois

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Télécharger Notice patient (PIL)
27-09-2020

Ingrédients actifs:

METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3%;;METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3%;;METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3%;;METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3%;;METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3%

Disponible depuis:

南光化學製藥股份有限公司 臺南市新化區全興里中山路1001號、1001-1號 (69275313)

Code ATC:

H02AB04

forme pharmaceutique:

乾粉注射劑

Composition:

METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3% (6804001333) (eq. to METHYLPREDNISOLONE 40mg)MG; METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3% (6804001333) (eq. to METHYLPREDNISOLONE 125mg)MG; METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3% (6804001333) (eq. to METHYLPREDNISOLONE 250mg)MG; METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3% (6804001333) (eq. to METHYLPREDNISOLONE 500mg)MG; METHYLPREDNISOLONE SODIUM SUCCINATE BUFFERED 3% (6804001333) (eq. to METHYLPREDNISOLONE 1G)GM

Unités en paquet:

盒裝;;玻璃小瓶裝

classe:

製 劑

Type d'ordonnance:

限由醫師使用

Fabriqué par:

南光化學製藥股份有限公司 台南市新化區全興里中山路1001號、1001之1號 TW

Domaine thérapeutique:

methylprednisolone

indications thérapeutiques:

腎上腺機能不全、劇烈休克、支氣管性氣喘、膠原疾病、過敏反應、泛發性感染

Descriptif du produit:

有效日期: 2028/08/06; 英文品名: MEDASON FOR INJECTION

Date de l'autorisation:

1986-08-06

Afficher l'historique des documents